Iqvia Holdings (IQV) Long-Term Debt Repayments (2012 - 2026)
Iqvia Holdings' (IQV) quarterly Long-Term Debt Repayments came in at $683.0 million in Q1 2026, down 67.41% year-on-year from $2.1 billion in Q1 2025, and down 72.86% quarter-over-quarter from $2.5 billion in Q4 2025.
Iqvia Holdings (IQV) Long-Term Debt Repayments (2012 - 2026) Analysis & Trends
Iqvia Holdings has disclosed Long-Term Debt Repayments across 15 years of filings, most recently posting $683.0 million for Q1 2026.
- Long-Term Debt Repayments for Q1 2026 came in at $683.0 million, down 67.41% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.8 billion (up 69.89% YoY), and the FY2025 annual result was $5.2 billion, up 2919.19% from the prior year.
- Long-Term Debt Repayments came in at $683.0 million for Q1 2026 at Iqvia Holdings, down from $2.5 billion in the prior quarter.
- In the past five years, Long-Term Debt Repayments ranged from a high of $2.8 billion in Q4 2023 to a low of $23.0 million in Q2 2022.
- The 5-year median for Long-Term Debt Repayments is $43.0 million (2024), against an average of $562.1 million.
- Across the five-year window, Long-Term Debt Repayments tumbled 98.63% in 2022 and surged 5892.86% in 2025, its largest moves.
- Iqvia Holdings' Long-Term Debt Repayments stood at $548.0 million in 2022, then surged by 402.74% to $2.8 billion in 2023, then tumbled by 98.48% to $42.0 million in 2024, then soared by 5892.86% to $2.5 billion in 2025, then slumped by 72.86% to $683.0 million in 2026.
- The last three Long-Term Debt Repayments figures came in at $683.0 million (Q1 2026), $2.5 billion (Q4 2025), and $536.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 3.70 Bn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 1.41 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | - |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | - |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 1.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | - |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 683.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | - |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | - |
| 10 | Quest Diagnostics | 22.51 Bn | 22.42 Bn | 942.00 Mn | 1.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 683.00 Mn |
| Mar 31, 2026 | 683.00 Mn |
| Dec 31, 2025 | 2.52 Bn |
| Dec 31, 2025 | 2.52 Bn |
| Sep 30, 2025 | 536.00 Mn |
| Sep 30, 2025 | 536.00 Mn |
| Jun 30, 2025 | 44.00 Mn |
| Jun 30, 2025 | 44.00 Mn |
| Mar 31, 2025 | 2.10 Bn |
| Mar 31, 2025 | 2.10 Bn |
| Dec 31, 2024 | 42.00 Mn |
| Dec 31, 2024 | 42.00 Mn |
| Sep 30, 2024 | 44.00 Mn |
| Sep 30, 2024 | 44.00 Mn |
| Jun 30, 2024 | 43.00 Mn |
| Jun 30, 2024 | 43.00 Mn |
| Mar 31, 2024 | 43.00 Mn |
| Mar 31, 2024 | 43.00 Mn |
| Dec 31, 2023 | 2.76 Bn |
| Dec 31, 2023 | 2.76 Bn |